BioNTech SE - ADR Stock News

Der Pharmakonzern Pfizer musste in den vergangenen Jahren damit kämpfen, dass die COVID-19-bedingten Umsätze weggebrochen sind. Nun wird der Neuanfang gewagt.

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennyslvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings on Friday.

Der Impfstoffhersteller Biontech US09075V1026 hat in den USA im Streit um Lizenzgebühren millionenschwere Vergleiche geschlossen.

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the inherent risks of developing new drugs.

BioNTech SE said on Friday it has been informed by its partner OncoC4 that the U.S. Food and Drug Administration has lifted the partial clinical hold on its late-stage trial studying its drug for a type of lung cancer.

I've long viewed healthcare as one of the best sectors for long-term investors because everybody requires healthcare products and services sooner or later. With aging populations in the U.S. and other major countries, the demand will almost certainly increase over the next decade and beyond.

I think the stock market's valuation has become frothy. And I'm in good company; Warren Buffett's actions show that he shares this opinion.

The end of the year can spur myriad feelings when deciding which stocks are the best buys.